三种新型三醇化合物的抗Pythium内部活性:合成,药理动力学和毒理学参数
Carolina Martins Fernandes1, Alessandro de Souza Prestes1, Lara Baccarin Ianiski2
1Department of Biochemistry and Molecular Biology, Federal University of Santa Maria, Santa Maria, RS, Brazil.
概括
三种新型的三醇化合物在治疗Pythiosis方面表现有前途,Pythium insidiosum引起的疾病. 这些化合物有效地抑制P. insidiosum的生长,而不会损害人体白细胞,这表明了潜在的新治疗途径.
科学领域:
- 菌类学和传染病的研究
- 药用化学 医学化学
- 毒理学 毒理学 毒理学
背景情况:
- 由Pythium insidiosum引起的Pythiosis是一种严重的传染病,治疗选择有限.
- 三醇化合物正在被研究其抗真菌和抗菌潜力.
- 开发安全有效的Pythiosis治疗方法是一个关键的未满足的医疗需求.
研究的目的:
- 合成和评估新的三醇化合物对Pythium insidiosum进行体外活性.
- 评估这些化合物对人类白细胞的安全性.
- 为了预测合成的三醇的药理动力学和毒理学概况.
主要方法:
- 合成了三种新的三醇化合物 (C1,C2,C3).
- 在体外对15种Pythium insidiosum分离物的敏感性测试以确定MIC和MOC.
- 人类白细胞毒性测定 (活力,形态,氧化应激).
- 在pkCSM平台使用in silico ADMET预测.
主要成果:
- 化合物C1和C2表现出抗Pythium insidiosum活性,MIC/MOC范围为2至64μg/mL.
- 化合物C3显示MIC在4-64μg/mL之间,MOC在8-64μg/mL之间.
- 三醇在人体白细胞中没有引起显著的毒性,没有显示生命力丧失,形态变化或亲氧化作用.
- 在基中,ADMET的预测与可纳的预测相当.
结论:
- 新型三醇化合物C1,C2和C3在体外对Pythium insidiosum表现出显著的活性.
- 这些化合物在活性度下对人体白细胞具有有利的安全性.
- 这些发现支持这些三醇作为Pythiosis治疗候选者的潜力.
更多相关视频
相关概念视频
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.8K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.8K
01:15Antifungal Agents
89
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
89
01:15Anthelminthic Agents
83
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
83